Tvardi Therapeutics(GB:0HTC)
$3.380.00 (0.00%)
GB:0HTC
Tvardi Therapeutics financials statements
$3.38
At close:0.00 (0.00%)
Tvardi Therapeutics (0HTC) Income Statement
4 Followers
Tvardi Therapeutics Income Statement
Last quarter (Q2 2026), Tvardi Therapeutics's total revenue was $0.00. In Q2, Tvardi Therapeutics's net income was $-6.46M. See Tvardi Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 7.14M | $ 20.97M | $ 41.87M | $ 23.03M | |
| $ -95.00K | $ 6.33M | $ 14.54M | $ 34.35M | $ 21.47M | |
| $ 26.75M | $ 62.11M | $ 136.03M | $ 121.89M | $ 110.56M | |
| Depreciation and Amortization | $ 95.00K | $ 192.00K | $ 259.00K | $ 85.00K | $ 1.55M |
| $ -18.12M | $ -62.60M | $ -117.65M | $ -85.39M | $ -86.89M | |
| $ -26.75M | $ -55.78M | $ -121.50M | $ -87.53M | $ -89.08M | |
| $ 8.53M | $ -15.48M | $ 2.98M | $ 2.06M | $ 642.00K | |
| $ -18.21M | $ -71.27M | $ -118.51M | $ -85.47M | $ -88.44M | |
| $ -18.21M | $ -70.87M | $ -118.51M | $ -85.47M | $ -88.44M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.46 | $ -46.59 | $ -1.85 | $ -2.20 | $ -62.77 |
| Diluted EPS | $ -3.26 | $ -46.59 | $ -1.85 | $ -2.20 | $ -62.77 |
| Weighted Average Shares Outstanding | 7.42M | 1.52M | 9.36M | 9.36M | 1.41M |
| Weighted Average Shares Outstanding (Diluted) | 7.78M | 1.52M | 9.36M | 9.36M | 1.41M |
Currency in USD
